Use your antibodies-online credentials, if available.
SLCO1B1 encodes a liver-specific member of the organic anion transporter family. 再加上，我们可以发SLCO1B1 抗体 (40) 和 SLCO1B1 蛋白 (3)和数多这个蛋白质的别的产品。
SLCO1B1 polymorphisms appear to be associated with the development of adverse drug reactions to regorafenib.
Polymorphisms in SLCO1B1 and UGT1A1 (显示 UGT1A1 ELISA试剂盒) are associated with several different sorafenib side effects
OATP1A2 (显示 SLCO1A2 ELISA试剂盒), OATP1B1, and OATP2B1 (显示 SLCO2B1 ELISA试剂盒) can mediate cellular uptake of ochratoxin A, which could aggravate OTA toxicity.
Our results did not indicate a strong association between OATP1B1 or OATP1B3 (显示 SLCO1B3 ELISA试剂盒) inhibition and hyperbilirubinemia
Polymorphisms of the SLCO1B1 gene ate used for predicting risk of adverse events when using statins.
Critical amino acid residues in the predicted transmembrane pore influencing transport kinetics of the hepatic drug transporter OATP1B1 have been identified.
Genetic polymorphisms of the UGT1A1 (显示 UGT1A1 ELISA试剂盒) promoter, specifically the T-3279G phenobarbital-responsive enhancer module and (TA)7 dinucleotide repeat, as well as the intron and coding region variants of the OATP2, HMOX1 (显示 HMOX1 ELISA试剂盒), and BLVRA (显示 BLVRA ELISA试剂盒) genes, were significantly higher among the cases than the controls.
SLCO1B1 genotype was not associated with the risk of statin-associated muscle symptoms.
these findings demonstrate an important role for OATP1B1 in the systemic pharmacokinetics of multiple drugs used in the treatment of acute myeloid leukemia (显示 BCL11A ELISA试剂盒)
Genetic link with cholelithiasis among pediatric SCA Tunisian patients: Examples of UGT1A1 (显示 UGT1A1 ELISA试剂盒), SLCO1A2 (显示 SLCO1A2 ELISA试剂盒) and SLCO1B1.
This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function.
, liver-specific organic anion transporter 1
, sodium-independent organic anion-transporting polypeptide 2
, solute carrier family 21 (organic anion transporter), member 6
, solute carrier family 21 member 6
, solute carrier organic anion transporter family member 1B1
, solute carrier organic anion transporter family, member 1B1
, solute carrier organic anion transporter family member 1B1-like